Sonoma Pharmaceuticals, Inc.
SNOA · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,457 | -$4,835 | -$5,151 | -$5,086 |
| Dep. & Amort. | $138 | $176 | $125 | $186 |
| Deferred Tax | $357 | -$109 | -$37 | -$829 |
| Stock-Based Comp. | $224 | $516 | $669 | $382 |
| Change in WC | $2,476 | $1,693 | -$1,864 | $3,131 |
| Other Non-Cash | $174 | $161 | $106 | -$2,032 |
| Operating Cash Flow | -$88 | -$2,398 | -$6,152 | -$4,248 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$80 | -$17 | -$269 | -$137 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $15 | $11 | $38 |
| Investing Cash Flow | -$80 | -$2 | -$258 | -$99 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$404 | -$481 | -$120 | -$374 |
| Stock Issued | $3,079 | $1,784 | $2,868 | $7,554 |
| Stock Repurch. | -$1 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $356 | $373 | -$259 | $216 |
| Financing Cash Flow | $3,030 | $1,676 | $2,489 | $7,396 |
| Forex Effect | -$616 | $32 | $345 | $127 |
| Net Chg. in Cash | $2,246 | -$692 | -$3,576 | $3,176 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,128 | $3,820 | $7,396 | $4,220 |
| End Cash | $5,374 | $3,128 | $3,820 | $7,396 |
| Free Cash Flow | -$168 | -$2,415 | -$6,421 | -$4,385 |